HSP90AA1 and neoplasm: Recent studies showed that dual silencing RNA (siRNA) inhibition of both HSP70 and HSC70 induced proteasome dependent degradation of HSP90 client proteins, G1 cell cycle arrest and tumor specific apoptosis [22].